MBody AI Ltd. (MBAI) stock
Close on Nov 16, 2026Market cap $14.60MP/E 3.2Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- $14.60M
- P/E ratio
- 3.2
- Price to sales
- –
- Price to book
- 4.25
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- $4.14M
- EPS, diluted
- $0.66
Trading
- Previous close
- $2.06
- Open
- $2.06
- Day's range
- $2.02 – $2.08
- Volume
- 7,022
- Average volume (20 days)
- 21,870
- 52-week range
- $1.61 – $27.44
- RSI (14 days)
- 38.1
- Volatility (1 year)
- 153.2%
- Relative volume
- 0.33×
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 16, 2026. The S&P 500 is measured by the SPY fund.
| Period | MBAI | S&P 500 | Difference | MBAI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.4% | -3.1% | −21.3 pts | ||
| 3 months | -76.1% | -4.5% | −71.7 pts | ||
| Year to date | -81.7% | +9.4% | −91.0 pts | ||
| 1 year | -85.0% | +11.3% | −96.3 pts | ||
| 3 years | -91.8% | +70.4% | −162.2 pts | -56.5% | +19.4% |
| 5 years | -98.4% | +68.6% | −167.0 pts | -56.1% | +11.0% |
| 10 years | -100.0% | +297.7% | −397.6 pts | -53.5% | +14.8% |
Fourteen years at a glance
Fiscal years 2012 to 2025, USD
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases MBody AI filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
About MBody AI
Services-Computer Integrated Systems Design
Check-Cap Ltd. is a clinical-stage medical diagnostics company focused on developing screening technologies for the gastrointestinal tract. Its primary product candidate is C-Scan, an ingestible capsule system comprising the C-Scan Cap, C-Scan Track, and C-Scan View. The system uses imaging alongside an oral contrast agent to detect colorectal abnormalities. Check-Cap designs its diagnostic solutions for patients requiring gastrointestinal screening, alongside physicians and clinical healthcare providers.
Company profile, executives and historyMBody AI stock: common questions
What is MBody AI's stock price?
MBAI closed at $2.08 on Nov 16, 2026, up 1.22% on the day. Over the past 52 weeks it traded between $1.61 and $27.44.
What is MBody AI's market cap?
MBody AI was worth $14.60M at the close on Nov 16, 2026: the share price times the diluted shares outstanding.
What is MBAI's P/E ratio?
MBAI trades at 3.2 times earnings, based on diluted earnings per share of $0.66 over fiscal 2025.
Does MBody AI pay a dividend?
No. MBody AI has not paid a cash dividend over the last twelve months.
How has MBAI stock performed over the past year?
Including dividends, MBAI returned -85.0% over the past year, against +11.3% for the S&P 500.
Who are MBody AI's competitors?
Companies most similar to MBody AI by business, industry and size include ODYS, OMQS, BNAI, ARBE, DAIC.
See a number that looks wrong?